A study of stem cell patent litigation sheds light on the current patent reform debate.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Allison, J.R. et al. Geo. L.J. 92, 435–476 (2004).
Parchomovsky, G. & Wagner, R.P. U. Pa. L. Rev. 154, 1–77 (2005).
Heller, M. & Eisenberg R.S. Sci. 280, 698–701 (1998).
Azher, A. I. U. Pa. J. Int'l. Econ. L. 25, 383–421 (2004).
110th Senate Judiciary Committee's Report on the Patent Reform Act of 2007. http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=110_cong_reports&docid=f:sr259.pdf
Federal Trade Commission. To Promote Innovation: The Proper Balance of Competition and Patent Law and Policy (FTC, 2003).
Merrill, S. et al. (eds.) A Patent System for the 21st Century (National Academies Press, Washington, DC, 2004).
National Research Council. Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation. Reaping the Benefits of Genomic and Protemic Research: Intellectual Property Rights, Innovation, and Public Health (National Academies Press, 2006).
Madey v. Duke University, 307 F.3d 1351 (N.C. 2002).
Whittemore v. Cutter, 29 F. Cas. 1120 1121 (C.C.D. Mass 1813).
Cert. denied 123 S. Ct. 2639 (2003).
Obama, B. Removing barriers to responsible scientific research involving human stem cells (The White House, 9 March, 2009) http://www.whitehouse.gov/the_press_office/Removing-Barriers-to-Responsible-Scientific-Research-Involving-Human-Stem-cells/
Bergman, K. & Graff, G.D. Nat. Biotechnol. 25, 419–424 (2007).
US Patent 5,352,605.
US Patent 4,940,835.
Walsh, J.P., Arora, A. & Cohen, W. in Patents in the Knowledge-Based Economy, (eds. Cohen W. & Merrill, S.) 285–340 (National Academies Press, Washington, DC, 2003).
35 USC 290, Notice of Patent Suits.
Acknowledgements
The authors would like to acknowledge M. Conway who performed the statistical analysis.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
A.E.M. and P.T. have been consultants for the Biotechnology Industry Organization on the issue that is the subject of this article.
Supplementary information
Supplementary Text and Figures
Supplementary Tables 1–7 (PDF 143 kb)
Rights and permissions
About this article
Cite this article
Mills, A., Tereskerz, P. Empirical analysis of major stem cell patent cases: the role of universities. Nat Biotechnol 28, 325–328 (2010). https://doi.org/10.1038/nbt0410-325
Issue Date:
DOI: https://doi.org/10.1038/nbt0410-325
This article is cited by
-
LULL(ed) into complacency: a perspective on licenses and stem cell translational science
Stem Cell Research & Therapy (2013)
-
Theory of knowledge and biotech patents: worlds apart?
Nature Biotechnology (2011)